Sodium‐glucose cotransporter‐2 inhibitors and the risk of gout in patients with type 2 diabetes mellitus: A propensity‐score‐matched, new‐user design study with an active comparator using the IQVIA Medical Research Data UK database

AIM: To conduct a pharmacoepidemiological study to explore the association between sodium‐glucose cotransporter‐2 (SGLT2) inhibitors and gout in patients with type 2 diabetes mellitus (T2DM). MATERIALS AND METHODS: A retrospective open cohort study using the IQVIA Medical Research Data UK database w...

Descripción completa

Detalles Bibliográficos
Autores principales: Subramanian, Anuradhaa, Gokhale, Krishna, Sainsbury, Christopher, Nirantharakumar, Krishnarajah, Toulis, Konstantinos A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087572/
https://www.ncbi.nlm.nih.gov/pubmed/36056476
http://dx.doi.org/10.1111/dom.14858

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087572/
https://www.ncbi.nlm.nih.gov/pubmed/36056476
http://dx.doi.org/10.1111/dom.14858

Ejemplares similares